ArticleAdvanced healthcare materials2026
Shelf-Stable, Rapid-Gelling, and Robust Thrombin-Independent Fibrinogen-Based Hydrogels for Massive Hemorrhage Control.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Effective hemorrhage control remains an important unmet need in trauma care and emergency medicine. Therefore, it is essential to achieve rapid and effective hemostasis. Bioadhesives offer an attractive approach to wound sealing, achieving simultaneous leakage prevention, mechanical support, and hemostasis. However, available bioadhesives are limited in clinical applications by weak mechanical strength, insufficient biocompatibility, and strict storage condition. In this study, a thrombin-independent fibrinogen-based hydrogel was developed, featuring rapid gelation, robust mechanical strength, strong tissue adhesion, and excellent shelf stability. This hydrogel is prepared from knob-peptide-grafted gelatin methacryloyl (GMK) and fibrinogen methacryloyl (FM). GMK/FM hydrogel can quickly form the knob-hole crosslinking and then be reinforced through photo-crosslinking. Compared with clinical standard-of-care fibrin glue, GMK/FM hydrogel demonstrates comparably rapid gelation (< 2 s), alongside enhanced mechanical strength, tissue adhesion and storage stability (4 weeks at room temperature). In rat severe hemorrhage models of liver and abdominal aorta, GMK/FM hydrogel decreased hemostatic time and blood loss remarkably. It demonstrates exceptional hemostatic performance, outstanding biocompatibility, and storage stability, holding significant promise for clinical applications and emergency uses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.